Respiratory syncytial virus‐associated acute respiratory illness in adult non‐immunocompromised patients: Outcomes, determinants of outcomes, and the effect of oral ribavirin treatment

BACKGROUND: Respiratory syncytial virus (RSV) is an increasingly common cause of respiratory illness in adult non‐immunocompromised patients. Oral ribavirin was reported to improve outcomes of RSV infection in immunocompromised patients. This study aimed to determine the outcomes of non‐immunocompro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wongsurakiat, Phunsup, Sunhapanit, Siwadol, Muangman, Nisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178057/
https://www.ncbi.nlm.nih.gov/pubmed/35150065
http://dx.doi.org/10.1111/irv.12971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178057/
https://www.ncbi.nlm.nih.gov/pubmed/35150065
http://dx.doi.org/10.1111/irv.12971

Ejemplares similares